why choose us

First received: January 06, 2023

Clinical Trial: Safety and Efficacy of Oral Administration of the Phage Cocktail, VRELysin™, In Healthy and VRE-Colonized Subjects

Study Status: Completed

Recruit Status: RECRUITING

Condition: Vancomycin-Resistant Enterococcal Colonization

Study Type: INTERVENTIONAL


Official Title: A Phase 1/2a Double-Blind, Randomized, Placebo-Controlled Trial to Assess the Safety and Efficacy of Oral Administration of the Phage Cocktail, VRELysin™, In Healthy And VRE-Colonized Subjects

Brief Summary: The study is a first-in-human Phase 1/2a randomized, double-blind, placebo-controlled trial to assess the clinical safety and efficacy of VRELysin in healthy and VRE-colonized adults.

Read more